2022
DOI: 10.1016/j.jbc.2022.102003
|View full text |Cite
|
Sign up to set email alerts
|

Genetic validation of Aspergillus fumigatus phosphoglucomutase as a viable therapeutic target in invasive aspergillosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 189 publications
0
1
0
Order By: Relevance
“…Nucleotide sugars, such as UDP-glucose, UDP-GlcNAc, and GDP-Man, are the precursors for cell wall biosynthesis [19][20][21]. Previously, AGM1, UAP1, GNA1, PMM, PGM, and PGI have been reported as potential drug targets against Aspergillus fumigatus [19][20][21][22][23][24].…”
Section: Introductionmentioning
confidence: 99%
“…Nucleotide sugars, such as UDP-glucose, UDP-GlcNAc, and GDP-Man, are the precursors for cell wall biosynthesis [19][20][21]. Previously, AGM1, UAP1, GNA1, PMM, PGM, and PGI have been reported as potential drug targets against Aspergillus fumigatus [19][20][21][22][23][24].…”
Section: Introductionmentioning
confidence: 99%